Flavio SOLCA

Person

Vienna, AT

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-cancer combination therapy
- Patent number 11,198,726
- Issue date Dec 14, 2021
- Boerhinger Ingelheim International GmbH
- Frank Hilberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 9,539,258
- Issue date Jan 10, 2017
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 9,089,571
- Issue date Jul 28, 2015
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating cancer harboring EGFR mutations
- Patent number 8,877,764
- Issue date Nov 4, 2014
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for EGFR directed combination treatment of non-small cell lu...
- Patent number 8,828,391
- Issue date Sep 9, 2014
- Boehringer Ingelheim International GmbH
- Louis Denis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles, pharmaceutical compositions containing these...
- Patent number 8,722,694
- Issue date May 13, 2014
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 8,623,887
- Issue date Jan 7, 2014
- Boehringer Ingelheim International GmbH
- Stephan Karl Zahn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives and pharmaceutical compositions containing...
- Patent number 8,586,608
- Issue date Nov 19, 2013
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives for the treatment of cancer diseases
- Patent number 8,404,697
- Issue date Mar 26, 2013
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocyclic compounds pharmaceutical compositions contain...
- Patent number 8,343,982
- Issue date Jan 1, 2013
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted indolines as tyrosine kinase inhibitors
- Patent number 8,207,179
- Issue date Jun 26, 2012
- Boehringer Ingelheim International GmbH
- Harald Engelhardt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives and pharmaceutical compositions containing...
- Patent number RE43431
- Issue date May 29, 2012
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Dihydropteridinone compounds
- Patent number 8,003,786
- Issue date Aug 23, 2011
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles, pharmaceutical compositions containing these...
- Patent number 7,863,281
- Issue date Jan 4, 2011
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combinations for the treatment of diseases involving cell prolifera...
- Patent number 7,846,936
- Issue date Dec 7, 2010
- Boehringer Ingelheim International GmbH
- Frank Hilberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating diseases or conditions using dihydropteridinon...
- Patent number 7,786,299
- Issue date Aug 31, 2010
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-benzylaminodihydropteridinones, process for their manufacture and...
- Patent number 7,759,347
- Issue date Jul 20, 2010
- Boehringer Ingelheim International GmbH
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediate compounds for making dihydropteridinones useful as pha...
- Patent number 7,750,152
- Issue date Jul 6, 2010
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-diaminopyrimidines useful for treating cell proliferation diseases
- Patent number 7,569,561
- Issue date Aug 4, 2009
- Boehringer Ingelheim International GmbH
- Heinz Stadtmueller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidines as PLK inhibitors
- Patent number 7,521,457
- Issue date Apr 21, 2009
- Boehringer Ingelheim International GmbH
- Heinz Stadtmueller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropteridione derivatives, process for their manufacture and th...
- Patent number 7,414,053
- Issue date Aug 19, 2008
- Boehringer Ingelheim International GmbH
- Matthias Grauert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropteridione derivatives, process for their manufacture and th...
- Patent number 7,332,491
- Issue date Feb 19, 2008
- Boehringer Ingelheim International, GmbH
- Matthias Grauert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-formyl-tetrahydropteridines, process for their manufacture and us...
- Patent number 7,241,889
- Issue date Jul 10, 2007
- Boehringer Ingelheim International GmbH
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles, pharmaceutical compositions containing these...
- Patent number 7,223,749
- Issue date May 29, 2007
- Boehringer Ingelheim International GmbH
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles, pharmaceutical compositions containing these...
- Patent number 7,220,750
- Issue date May 22, 2007
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocyclic compounds, pharmaceutical compositions contai...
- Patent number 7,119,084
- Issue date Oct 10, 2006
- Boehringer Ingelheim International GmbH
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives and pharmaceutical compositions containing...
- Patent number 7,019,012
- Issue date Mar 28, 2006
- Boehringer Ingelheim International Pharma GmbH & Co. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-amino-quinazoline and quinoline derivatives having an inhibitory...
- Patent number 6,972,288
- Issue date Dec 6, 2005
- Boehringer Ingelheim Pharma KG
- Frank Himmelsbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocyclic compounds, pharmaceutical compositions contai...
- Patent number 6,924,285
- Issue date Aug 2, 2005
- Boehringer Ingelheim Pharma GmbH & Co.
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropteridinones, processes for preparing them and their use as...
- Patent number 6,861,422
- Issue date Mar 1, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI CANCER COMBINATION THERAPY
- Publication number 20220340651
- Publication date Oct 27, 2022
- Boehringer Ingelheim International GmbH
- Frank Hilberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER COMBINATION THERAPY
- Publication number 20190125751
- Publication date May 2, 2019
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20180360834
- Publication date Dec 20, 2018
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER COMBINATION THERAPY
- Publication number 20180346559
- Publication date Dec 6, 2018
- Boehringer Ingelheim International GmbH
- Frank Hilberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
- Publication number 20180086744
- Publication date Mar 29, 2018
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
- Publication number 20170312360
- Publication date Nov 2, 2017
- Boehringer Ingelheim International GmbH
- Louis Jean DENIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20170112835
- Publication date Apr 27, 2017
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER COMBINATION THERAPY
- Publication number 20170088609
- Publication date Mar 30, 2017
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
- Publication number 20160101175
- Publication date Apr 14, 2016
- Boehringer Ingelheim International GmbH
- Louis DENIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20150272954
- Publication date Oct 1, 2015
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...
- Publication number 20150265610
- Publication date Sep 24, 2015
- Boehringer Ingelheim International GmbH
- Martin Friedrich STEFANIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
- Publication number 20140341926
- Publication date Nov 20, 2014
- Boehringer Ingelheim International GmbH
- Louis DENIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
- Publication number 20140199298
- Publication date Jul 17, 2014
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER THERAPY
- Publication number 20140194442
- Publication date Jul 10, 2014
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES
- Publication number 20140066456
- Publication date Mar 6, 2014
- Boehringer Ingelheim International GmbH
- Joanne Van Ryn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...
- Publication number 20140057898
- Publication date Feb 27, 2014
- Boehringer Ingelheim International GmbH
- Martin Friedrich STEFANIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy in treatment of oncological and fibrotic diseases
- Publication number 20130289014
- Publication date Oct 31, 2013
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS
- Publication number 20130281429
- Publication date Oct 24, 2013
- Boehringer Ingelheim International GmbH
- Stephan Karl ZAHN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
- Publication number 20130178487
- Publication date Jul 11, 2013
- Boehringer Ingelheim International GmbH
- Flavio SOLCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
- Publication number 20130012465
- Publication date Jan 10, 2013
- Boehringer Ingelheim International GmbH
- Christian Haslinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER THERAPY
- Publication number 20130004481
- Publication date Jan 3, 2013
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE...
- Publication number 20120329778
- Publication date Dec 27, 2012
- BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
- Frank Himmelsbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
- Publication number 20120294867
- Publication date Nov 22, 2012
- Boehringer Ingelheim International GmbH
- Louis DENIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING COLORECTAL CANCER
- Publication number 20120157472
- Publication date Jun 21, 2012
- Boehringer Ingelheim International GmbH
- Annette Larsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES
- Publication number 20120136004
- Publication date May 31, 2012
- Boehringer Ingelheim International GmbH
- Joanne Van Ryn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy in treatment of oncological and fibrotic diseases
- Publication number 20120107304
- Publication date May 3, 2012
- Boehringer Ingelheim International GmbH
- Flavio Solca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS
- Publication number 20110251174
- Publication date Oct 13, 2011
- Boehringer Ingelheim International GmbH
- Stephan Karl ZAHN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...
- Publication number 20110171289
- Publication date Jul 14, 2011
- Boehringer Ingelheim International GmbH
- Martin Friedrich STEFANIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...
- Publication number 20110136826
- Publication date Jun 9, 2011
- Boehringer Ingelheim International GmbH
- Frank HILBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrimidines as PLK inhibitors
- Publication number 20110086842
- Publication date Apr 14, 2011
- Boehringer Ingelheim International GmbH
- Heinz STADTMUELLER
- C07 - ORGANIC CHEMISTRY

Flavio SOLCA

Person

Patents Grantslast 30 patents

Anti-cancer combination therapy

Quinazoline derivatives for the treatment of cancer diseases

Quinazoline derivatives for the treatment of cancer diseases

Method for treating cancer harboring EGFR mutations

Method for EGFR directed combination treatment of non-small cell lu...

Bicyclic heterocycles, pharmaceutical compositions containing these...

Compounds

Quinazoline derivatives and pharmaceutical compositions containing...

Quinazoline derivatives for the treatment of cancer diseases

Bicyclic heterocyclic compounds pharmaceutical compositions contain...

Substituted indolines as tyrosine kinase inhibitors

Quinazoline derivatives and pharmaceutical compositions containing...

Dihydropteridinone compounds

Bicyclic heterocycles, pharmaceutical compositions containing these...

Combinations for the treatment of diseases involving cell prolifera...

Methods for treating diseases or conditions using dihydropteridinon...

2-benzylaminodihydropteridinones, process for their manufacture and...

Intermediate compounds for making dihydropteridinones useful as pha...

2,4-diaminopyrimidines useful for treating cell proliferation diseases

Pyrimidines as PLK inhibitors

Dihydropteridione derivatives, process for their manufacture and th...

Dihydropteridione derivatives, process for their manufacture and th...

6-formyl-tetrahydropteridines, process for their manufacture and us...

Bicyclic heterocycles, pharmaceutical compositions containing these...

Bicyclic heterocycles, pharmaceutical compositions containing these...

Bicyclic heterocyclic compounds, pharmaceutical compositions contai...

Quinazoline derivatives and pharmaceutical compositions containing...

4-amino-quinazoline and quinoline derivatives having an inhibitory...

Bicyclic heterocyclic compounds, pharmaceutical compositions contai...

Dihydropteridinones, processes for preparing them and their use as...

Patents Applicationslast 30 patents

ANTI CANCER COMBINATION THERAPY

ANTICANCER COMBINATION THERAPY

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

ANTI-CANCER COMBINATION THERAPY

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

ANTICANCER COMBINATION THERAPY

METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...

METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

ANTICANCER THERAPY

COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...

Combination therapy in treatment of oncological and fibrotic diseases

2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

ANTICANCER THERAPY

BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE...

METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER

METHOD FOR TREATING COLORECTAL CANCER

NEW COMBINATION THERAPY IN TREATMENT OF CANCER AND FIBROTIC DISEASES

Combination therapy in treatment of oncological and fibrotic diseases

2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERA...

Pyrimidines as PLK inhibitors